Moderna’s vaccine candidate against the Omicron coronavirus variant will enter clinical development in the next few weeks and the company expects to be able to share data with regulators in about March, CEO Stephane Bancel said on Monday.
“Our goal is to be able to have a single annual booster so that we don't have compliance issues where people don’t want to get two to three shots a winter.” Earlier in January, Moderna’s CEO said people may need a fourth shot in the northern hemisphere’s autumn of 2022 as the efficacy of boosters against Covid-19 was likely to decline over the next few months.
Speaking at the same event, top US infectious disease expert Anthony Fauci said there was no evidence that repeat booster doses would overwhelm the immune system.
👏🏼
That's amazing journey with you 💝 I just received this on my bitcoin.com wallet thanks Mr Hendricksnino77 for his profits don't doubt his words this guy is gentlemen and God 🙏 sent 🇿🇦🇿🇦 interested persons 👉Connect with him directly on WhatsApp
South Africa Latest News, South Africa Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.